Proposal to establish a register for the long term surveillance of adverse events in patients with rheumatic diseases exposed to biological agents: The EULAR Surveillance Register for Biological Compounds

Annals of the Rheumatic Diseases

Volumn 59, Issue 6, 2000, Pages 419-420

  Silman, A ^a   Klareskog, L ^a   Breedveld, F ^a   Bresnihan, B ^a   Maini, R ^a   Van Riel, P ^a   Symmons, D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ETANERCEPT; INFLIXIMAB; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TUMOR NECROSIS FACTOR;

DATA ANALYSIS; ENVIRONMENTAL FACTOR; FOLLOW UP; HYPOTHESIS; INFECTION RISK; LONG TERM CARE; MORTALITY; NOTE; PRIORITY JOURNAL; QUESTIONNAIRE; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; RISK FACTOR; TREATMENT OUTCOME;

ADVERSE DRUG REACTION REPORTING SYSTEMS; BIOLOGICAL RESPONSE MODIFIERS; HUMANS; REGISTRIES; RHEUMATIC DISEASES; RISK; TIME FACTORS;

EID: 0034130046     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.59.6.419     Document Type: Note

References (14)